Artículos por temáticas

Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis.

Ferlazzo E, Striano P, Italiano D, Calarese T, Gasparini S, Vanni N, Fruscione F, Genton P, Zara F.

Epileptic Disord. 2016 Sep 1;18(S2):120-127.

Post-modern therapeutic approaches for progressive myoclonus epilepsy.

Minassian BA.

Epileptic Disord. 2016 Sep 1;18(S2):154-158.

Poster 396 Gabapentin-Induced Myoclonus in Spinal Cord Injury.

Schnitzer O, Gober JF, Dalal K.

PM R. 2016 Sep;8(9S):S290-S291. doi: 10.1016/j.pmrj.2016.07.323. No abstract available.

Progressive myoclonus epilepsy associated with SACS gene mutations.

Nascimento FA, Canafoglia L, Aljaafari D, Muona M, Lehesjoki AE, Berkovic SF, Franceschetti S, Andrade DM.

Neurol Genet. 2016 Jun 23;2(4):e83. doi: 10.1212/NXG.0000000000000083.

Adult-onset opsoclonus-myoclonus syndrome due to West Nile Virus treated with intravenous immunoglobulin.

Hébert J, Armstrong D, Daneman N, Jain JD, Perry J.

J Neurovirol. 2016 Jul 29. [Epub ahead of print]

Prolonged drug-induced myoclonus: is it related to palonosetron?

Chaw SH, Chan L, Lee PK, Bakar JA, Rasiah R, Foo LL.

J Anesth. 2016 Dec;30(6):1063-1066.

SCARB2/LIMP2 deficiency in action myoclonus-renal failure syndrome.

Dibbens L, Schwake M, Saftig P, Rubboli G.

Epileptic Disord. 2016 Sep 1;18(S2):63-72.

Myoclonus epilepsy in mitochondrial disorders.

Lamperti C, Zeviani M.

Epileptic Disord. 2016 Sep 1;18(S2):94-102.

Don't startle me-Interference of startle probe presentations and intermittent ratings with fear acquisition.

Sjouwerman R, Niehaus J, Kuhn M, Lonsdorf TB.

Psychophysiology. 2016 Dec;53(12):1889-1899. doi: 10.1111/psyp.12761.

Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab.

Magira EE, Alexopoulos H, Charitatos E, Michas D, Dalakas MC.

Ther Adv Neurol Disord. 2016 Jan;9(1):69-73. doi: 10.1177/1756285615614812. No abstract available.

Altered functional brain connectivity in children and young people with opsoclonus-myoclonus syndrome.

Chekroud AM, Anand G, Yong J, Pike M, Bridge H.

Dev Med Child Neurol. 2016 Sep 23. doi: 10.1111/dmcn.13262. [Epub ahead of print]

Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Armangué T, Sabater L, Torres-Vega E, Martínez-Hernández E, Ariño H, Petit-Pedrol M, Planagumà J, Bataller L, Dalmau J, Graus F.

JAMA Neurol. 2016 Apr;73(4):417-24. doi: 10.1001/jamaneurol.2015.4607.

Neurophysiology of myoclonus and progressive myoclonus epilepsies.

Avanzini G, Shibasaki H, Rubboli G, Canafoglia L, Panzica F, Franceschetti S, Hallett M.

Epileptic Disord. 2016 Sep 1;18(S2):11-27.

Benign adult familial myoclonus epilepsy is a progressive disorder: no longer idiopathic generalized epilepsy.

Hitomi T, Kobayashi K, Sakurai T, Ueda S, Jingami N, Kanazawa K, Matsumoto R, Takahashi R, Ikeda A.

Epileptic Disord. 2016 Mar;18(1):67-72. doi: 10.1684/epd.2016.0807.

Foreknowledge of an impending startling stimulus does not affect the proportion of startle reflexes or latency of StartReact responses.

Drummond NM, Leguerrier A, Carlsen AN.

Exp Brain Res. 2016 Oct 13. [Epub ahead of print]